Products
Fees
Download

Promotions

Welcome Rewards Referral Program US Pre-Market Options Trading

For Institutions

Corporate Services Developers

Help

About

About Longbridge License & Regulatory Media Coverage Join Us

Home
Discover
News & Info
Trade
LongbridgeAI

Discover

News & Info

Quote List Quote List

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)(520500.SH)

Last Updated 00:00:00

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII) Stock Performance Chart

longbridge loading

© 2026 Longbridge｜Disclaimer

Event Tracking

Mar24

JPMorgan Increases Stake in Innovent Biologics by 497,823 Shares

11:19

Goldman Sachs Reiterates Buy Rating on Kolon Biotech, Sees Strong Prospects for Core Product

10:36

Colen Biopharma's Self-developed Novel Bispecific Antibody-Drug Conjugate SKB103 Approved for Clinical Trials by NMPA

08:49

Goldman Sachs Publishes Report on Kolon Biotech-B's Performance and Forecast

02:31

UBS Reports on Kexium Biologics' Performance and Adjusts Target Price

02:19

Mar23

SKB BIO-B released FY2025 Q3 earnings on March 23 (BJT) with actual revenue HKD 0 and actual EPS HKD 0

15:00